Philip Nickson - 01 Mar 2022 Form 3 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
General Counsel
Signature
/s/ Ajim Tamboli, Attorney-in-Fact
Issuer symbol
GLUE
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
3
Filing time
02 Mar 2022, 17:39:00 UTC
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLUE Stock Option (Right to Buy) 01 Mar 2022 Common Stock 65,146 $7.87 Direct F1
holding GLUE Stock Option (Right to Buy) 01 Mar 2022 Common Stock 50,974 $19.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on May 10, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
F2 25% of this option shall vest and become exercisable on June 24, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney